Dalteparin sodium
Sponsors
Academisch Ziekenhuis Leiden, Pfizer, Ottawa Hospital Research Institute, Denver Health and Hospital Authority, Imperial College London
Conditions
DalteparinDeep Vein ThrombosisPostpartumPregnancyPregnancy ComplicationsThromboembolismThrombophiliaVaricose Veins
Phase 3
Phase 4
Prophylaxis In Venous Thromboembolism In Primary Care, A Pilot Study
TerminatedNCT00655122
Start: 2003-04-30End: 2003-12-31Updated: 2008-09-29
THRomboprophylaxis in Individuals Undergoing Superficial endoVEnous Treatment (THRIVE)
RecruitingNCT05735639
Start: 2024-01-22End: 2026-12-31Target: 6660Updated: 2025-05-02
DISTINCT: inDividual, targeted thrombosIS prophylaxis versus the standard ‘one size fits all’ approach in patients undergoing Total hIp or total kNee replaCemenT: a national, multicenter, randomized, multi-arm, open-label trial
RecruitingCTIS2023-510186-98-00
Start: 2024-10-23Target: 10078Updated: 2025-11-14